Research graph
References from Drug-Eluting Resorbable Scaffolds for Infrapopliteal Peripheral Artery Disease: A State-of-the-Art Review. Local targets link to admitted publications; unresolved targets remain external evidence.
Cardiovascular Statistics in the United States, 2026
10.1016/j.jacc.2025.12.027 · 2026 · External reference
Using the epidemiology of critical limb ischemia to estimate the number of patients amenable to endovascular therapy
10.1177/1358863x19878271 · 2020 · External reference
Updated estimates for the burden of chronic limb-threatening ischemia in the Medicare population
10.1016/j.jvs.2023.01.200 · 2023 · External reference
Endovascular Interventions for Peripheral Artery Disease: A Contemporary Review
10.1007/s11886-023-01973-9 · 2023 · External reference
Variations in Revascularization Strategies for Chronic Limb-Threatening Ischemia: A Nationwide Analysis of Medicare Beneficiaries
10.1016/j.jcin.2024.09.024 · 2025 · External reference
Global Vascular Guidelines on the Management of Chronic Limb Threatening Ischemia
10.1016/j.ejvs.2019.05.006 · 2019 · External reference
ACC /AHA / SCAI / SIR / SVM 2018 Appropriate Use Criteria for Peripheral Artery Intervention
10.1016/j.jacc.2018.10.002 · 2019 · External reference
A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation pr
10.1016/s0140-6736(23)00462-2 · 2023 · External reference
Long-term outcomes of patients with diabetes mellitus undergoing percutaneous intervention for popliteal and infrapopliteal peripheral arterial disease
2018 · External reference
Intravascular Lithotripsy for Treatment of Calcified Infrapopliteal Lesions: Results from the Disrupt PAD III Observational Study
2022 · External reference
Angiographic Patency and Clinical Outcome After Balloon-Angioplasty for Extensive Infrapopliteal Arterial Disease
2010 · External reference
Subintimal Angioplasty of Isolated Infragenicular Vessels in Lower Limb Ischemia: Long-term Results
10.1177/152660280200900404 · 2002 · External reference
Bioresorbable Scaffolds for Below-the-Knee Arterial Disease: A Literature Review of New Developments
2024 · External reference
A systematic review and meta-analysis of bioresorbable vascular scaffolds for below-the-knee arterial disease
10.23736/s0392-9590.20.04462-4 · 2021 · External reference
Efficacy and Safety of Absorb Everolimus- Eluting Bioresorbable Vascular Scaffold in Peripheral Artery Disease: A Single-Arm Meta-Analysis
10.1177/15266028221091899 · 2023 · External reference
Unresolved reference
2016 · External reference
Clinical Outcomes Before and After Complete Everolimus-Eluting Bioresorbable Scaffold Resorption Five-Year Follow-Up From the ABSORB III Trial
10.1161/circulationaha.119.042584 · 2019 · External reference
Time-Varying Outcomes With the Absorb Bioresorbable Vascular Scaffold During 5-Year Follow-up A Systematic Meta-analysis and Individual Patient Data Pooled Study
10.1001/jamacardio.2019.4101 · 2019 · External reference
Bioresorbable Vascular Scaffolds for Coronary Revascularization
10.1161/circulationaha.116.021539 · 2016 · External reference
The Demise of the Absorb BVS: Lessons Learned From the Discontinuation of a Disappearing Stent
10.1177/1526602818799735 · 2018 · External reference
Clinical Outcomes Before and After Complete Everolimus-Eluting Bioresorbable Scaffold Resorption: Five-Year Follow-Up From the ABSORB III Trial
10.1161/circulationaha.119.042584 · 2019 · External reference
Unresolved reference
2017 · External reference
Bioresorbable scaffolds in peripheral arterial disease
10.1586/14779072.2014.897226 · 2014 · External reference
Initial Experience With the Absorb Bioresorbable Vascular Scaffold Below the Knee: Six-Month Clinical and Imaging Outcomes
10.1177/1526602815575256 · 2015 · External reference
Experience With the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold in Arteries Below the Knee: 12-Month Clinical and Imaging Outcomes
10.1016/j.jcin.2016.06.005 · 2016 · External reference
Three-Year Results of the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold in Infrapopliteal Arteries
2018 · External reference
Long-term results of a prospective, single-arm evaluation of everolimus-eluting bioresorbable vascular scaffolds in infrapopliteal arteries
2021 · External reference
Early and Midterm Experience With the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold in Asian Patients With Chronic Limb-Threatening Ischemia: One-Year Clinical and Imaging Outcomes From the DISAPEAR Registry
10.1177/1526602820922524 · 2020 · External reference
Single arm retrospective study of bioresorbable vascular scaffolds to treat patients with severe infrapopliteal arterial disease
2019 · External reference
Two-year follow-up of bioresorbable vascular scaffolds in severe infra-popliteal arterial disease
10.1177/1708538120954947 · 2021 · External reference
Evaluation of an Infrapopliteal Drug-Eluting Resorbable Scaffold: Design Methodology for the LIFE-BTK Randomized Controlled Trial
2023 · External reference
From Coronary Arteries to Lower Limbs: Advances in Drug-Eluting Bioresorbable Scaffolds for Treating Chronic Limb- Threatening Ischemia
2025 · External reference
Pharmacokinetic Profile of Everolimus Eluted From the Esprit BTK Scaffold: A LIFE-BTK Pharmacokinetics Substudy
2026 · External reference
Drug-Eluting Resorbable Scaffold versus Angioplasty for Infrapopliteal Artery Disease
10.1056/nejmoa2305637 · 2024 · External reference
Absorbable Drug Eluting Stents May Bring LIFE to the Treatment of Below the Knee Lesions in Peripheral Arterial Disease
10.1016/j.ejvs.2024.05.021 · 2024 · External reference
Drug-Eluting Resorbable Scaffold Versus Balloon Angioplasty for Below-the-Knee Peripheral Artery Disease: 2-Year Results From the LIFE-BTK Trial
10.1161/circulationaha.125.075080 · 2025 · External reference
Three-Year Outcomes of the LIFE-BTK Randomized Controlled Trial Evaluating the EspritTM BTK Drug-Eluting Resorbable Scaffold for Treatment of Infrapopliteal Lesions
2025 · External reference
Unresolved reference
2025 · External reference
The preclinical study of biocompatibility of tyrosine polycarbonate bioresorbable scaffold in small caliber porcine peripheral arteries
10.1038/s41598-025-91759-6 · 2025 · External reference
MOTIV Bioresorbable Scaffold in Below-The-Knee Artery Disease: European Post-Market Pilot BTK Trial: 36-Month Results
10.1007/s00270-025-04202-8 · 2025 · External reference
Magnetic resonance angiography in diagnostic long-term follow-up of primary patency of the MOTIV drug-eluting bioresorbable vascular scaffold in the region below the knee: 5 years of experience
2025 · External reference
Unresolved reference
2025 · External reference
In vitro mechanical behavior and in vivo healing response of a novel thin-strut ultrahigh molecular weight poly- L -lactic acid sirolimus-eluting bioresorbable coronary scaffold in normal swine
10.1016/j.ijcard.2019.04.012 · 2019 · External reference
Clinical and Angiographic Outcomes of a Novel Thin Strut Poly (L-lactide) Based Bioresorbable Vascular Scaffold in Below Knee Arterial Disease: The RESOLV I First in Human Study
2025 · External reference
Unresolved reference
2026 · External reference
Preliminary Results After Application of Absorbable Metal Stents in Patients With Critical Limb Ischemia
10.1583/04-1349r.1 · 2005 · External reference
First Clinical Application of Absorbable Metal Stents in the Treatment of Critical Limb Ischemia: 12-Month Results
2005 · External reference
AMS INSIGHT — Absorbable Metal Stent Implantation for Treatment of Below-the-Knee Critical Limb Ischemia: 6-Month Analysis
10.1007/s00270-008-9472-8 · 2009 · External reference
Sustained Safety and Performance of the Second-Generation Sirolimus-Eluting Absorbable Metal Scaffold: Pooled Outcomes of the BIOSOLVE-II and -III Trials at 3 Years
10.1016/j.carrev.2020.04.006 · 2020 · External reference
The bioresorbable magnesium scaffold (Magmaris) — State of the art: From basic concept to clinical application
2022 · External reference
In vitro performance investigation of bioresorbable scaffolds – Standard tests for vascular stents and beyond
10.1016/j.carrev.2016.05.001 · 2016 · External reference
Magmaris resorbable magnesium scaffold for the treatment of coronary heart disease: overview of its safety and efficacy
10.1080/17434440.2019.1649133 · 2019 · External reference
Preclinical evaluation of degradation kinetics and elemental mapping of first- and second-generation bioresorbable magnesium scaffolds
10.4244/eij-d-17-00708 · 2018 · External reference
Preclinical evaluation of the degradation kinetics of third- generation resorbable magnesium scaffolds
10.4244/eij-d-22-00718 · 2023 · External reference
Sirolimus – Eluting Resorbable Magnesium Scaffold for the Treatment of Patients With Infrapopliteal Arteries Disease: Three-Year Results
2025 · External reference
A new resorbable magnesium scaffold for de novo coronary lesions (DREAMS 3): one-year results of the BIOMAG-I first- in-human study
10.4244/eij-d-23-00326 · 2023 · External reference
Unresolved reference
2025 · External reference
TCT CONNECT-317 Twelve-Month Clinical Outcomes of Sirolimus-Eluting Bioresorbable Peripheral Scaffold System Following Percutaneous Transluminal Angioplasty of Below-the-Knee Arteries in Patients With Critical Limb Ischemia: The CREDENCE BtK-1 Study
10.1016/j.jacc.2020.09.337 · 2020 · External reference
Unresolved reference
2022 · External reference
Safety and Efficacy of Endovascular Treatment Modalities for Below-the-Knee Arterial Disease: A Systematic Review and Network Meta-analysis
2025 · External reference
Contemporary Indications for Bioresorbable Scaffolds for Infrapopliteal Peripheral Artery Disease: An International Expert Consensus
2026 · External reference
Drug-eluting resorbable scaffold proves cost effective at one year in LIFE-BTK analysis
2024 · External reference
Mid-term outcomes of an everolimus- eluting bioresorbable vascular scaffold in patients with below-the-knee arterial disease: A pooled analysis of individual patient data
10.1177/1358863x20977907 · 2021 · External reference
Abluminal biodegradable polymer-based Biolimus A9-eluting stent for the treatment of infrapopliteal arteries in critical limb ischemia: Long-term follow-up
10.1016/j.ijcard.2015.08.178 · 2016 · External reference
Peripheral Matters | Bioresorbable Stents in Below-the-Knee Arterial Disease
2024 · External reference
